Literature DB >> 34988885

Sexuality in breast cancer survivors: sexual experiences, emotions, and cognitions in a group of women under hormonal therapy.

F M Nimbi1, S Magno2, L Agostini2, A Di Micco2, C Maggiore2, B M De Cesaris2, R Rossi3, R Galizia4, C Simonelli4, R Tambelli4.   

Abstract

BACKGROUND: Earlier diagnosis and improved treatments have led to better outcomes in breast cancer, making quality of life a key issue. Sexuality represents a pillar of quality of life, although it is often neglected by both healthcare providers and patients when it comes to cancer. This study aims to explore the differences in sexual functioning, distress, psychopathology, emotions, and cognitions between breast cancer patients under hormonal treatment and controls.
METHODS: Seventy-nine women (age range between 24 and 69 years) in hormonal therapy for breast cancer completed a self-reported protocol. A matched control group of 103 women was randomly extracted from an Italian general population database. Eight self-report questionnaires exploring biopsychosocial factors were administered.
RESULTS: The current study showed an impaired sexuality in breast cancer patients compared to controls. Breast cancer women under hormonal treatment were characterized by diminished or absent sexual activity (chi2 = 36.16; p < 0.001), lower level of sexual functioning in all areas except for pain (F(1,180) = 8.1; p < 0.01), higher sexual (F(1,180) = 10.08; p < 0.001) and psychological distress (F(1,180) = 6.23; p < 0.05), higher scores in Difficulties in Identifying Feelings (F(1,180) = 7.31; p < 0.01) and Externally Oriented Thinking (F(1,180) = 6.64; p < 0.05), higher level of negative emotions related to sexuality (F(1,180) = 11.13; p < 0.001), and more rigid cognition towards peculiar aspects of sexuality, such as Failure Disengagement Thoughts (F(1,180) = 22.01; p < 0.001) and Age related Beliefs (F(1,180) = 5.7; p < 0.05).
CONCLUSIONS: Health care providers do not usually assess those issues in their routine practice, so that sexuality remains an unmet need with remarkable effects on general health and quality of life.
© 2021. The Author(s), under exclusive licence to The Japanese Breast Cancer Society.

Entities:  

Keywords:  Biopsychosocial model; Breast cancer; Cognitions; Hormonal therapy; Sexual functioning

Mesh:

Year:  2022        PMID: 34988885     DOI: 10.1007/s12282-021-01320-2

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   3.307


  27 in total

1.  The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function.

Authors:  R Rosen; C Brown; J Heiman; S Leiblum; C Meston; R Shabsigh; D Ferguson; R D'Agostino
Journal:  J Sex Marital Ther       Date:  2000 Apr-Jun

2.  Fertility, sexuality and cancer in young adult women.

Authors:  Margherita Condorelli; Matteo Lambertini; Lucia Del Mastro; Francesco Boccardo; Isabelle Demeestere; Sharon L Bober
Journal:  Curr Opin Oncol       Date:  2019-07       Impact factor: 3.645

3.  Sexual health in long-term breast cancer survivors.

Authors:  Sara V Soldera; Marguerite Ennis; Ana E Lohmann; Pamela J Goodwin
Journal:  Breast Cancer Res Treat       Date:  2018-07-19       Impact factor: 4.872

4.  Breast-Specific Sensuality and Sexual Function in Cancer Survivorship: Does Surgical Modality Matter?

Authors:  Jennifer S Gass; Michaela Onstad; Sarah Pesek; Kristin Rojas; Sara Fogarty; Ashley Stuckey; Christina Raker; Don S Dizon
Journal:  Ann Surg Oncol       Date:  2017-06-12       Impact factor: 5.344

5.  Patients' perceived barriers to discussing sexual health with breast cancer healthcare providers.

Authors:  Lauren A Zimmaro; Stephen J Lepore; Mary Catherine Beach; Jennifer B Reese
Journal:  Psychooncology       Date:  2020-04-16       Impact factor: 3.894

6.  Trends in Sexual Function After Breast Cancer Surgery.

Authors:  Lauren F Cornell; Dawn M Mussallem; Tammeza C Gibson; Nancy N Diehl; Sanjay P Bagaria; Sarah A McLaughlin
Journal:  Ann Surg Oncol       Date:  2017-05-30       Impact factor: 5.344

7.  Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health.

Authors:  Stephanie S Faubion; Lisa C Larkin; Cynthia A Stuenkel; Gloria A Bachmann; Lisa A Chism; Risa Kagan; Andrew M Kaunitz; Michael L Krychman; Sharon J Parish; Ann H Partridge; JoAnn V Pinkerton; Tami S Rowen; Marla Shapiro; James A Simon; Shari B Goldfarb; Sheryl A Kingsberg
Journal:  Menopause       Date:  2018-06       Impact factor: 2.953

8.  The Female Sexual Distress Scale (FSDS): initial validation of a standardized scale for assessment of sexually related personal distress in women.

Authors:  Leonard R Derogatis; Raymond Rosen; Sandra Leiblum; Arthur Burnett; Julia Heiman
Journal:  J Sex Marital Ther       Date:  2002 Jul-Sep

9.  Sexual health care in cancer patients: A survey of healthcare providers' knowledge, attitudes and barriers.

Authors:  Dhuha Youssef Wazqar
Journal:  J Clin Nurs       Date:  2020-08-26       Impact factor: 3.036

10.  The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition.

Authors:  Tatsunori Shimoi; Shigenori E Nagai; Tetsuhiro Yoshinami; Masato Takahashi; Hitoshi Arioka; Mikiya Ishihara; Yuichiro Kikawa; Kei Koizumi; Naoto Kondo; Yasuaki Sagara; Masahiro Takada; Toshimi Takano; Junji Tsurutani; Yoichi Naito; Rikiya Nakamura; Masaya Hattori; Fimikata Hara; Naoki Hayashi; Toshiro Mizuno; Minoru Miyashita; Nami Yamashita; Takashi Yamanaka; Shigehira Saji; Hiroji Iwata; Tatsuya Toyama
Journal:  Breast Cancer       Date:  2020-04-02       Impact factor: 4.239

View more
  1 in total

1.  Endometriosis and Sexual Functioning: How Much Do Cognitive and Psycho-Emotional Factors Matter?

Authors:  Valentina Rossi; Roberta Galizia; Francesca Tripodi; Chiara Simonelli; Maria Grazia Porpora; Filippo Maria Nimbi
Journal:  Int J Environ Res Public Health       Date:  2022-04-27       Impact factor: 4.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.